101 related articles for article (PubMed ID: 3082771)
21. Membrane structures involved in auto-tumor recognition.
Vánky F
Biochim Biophys Acta; 1986 Dec; 865(3):253-65. PubMed ID: 3539197
[TBL] [Abstract][Full Text] [Related]
22. Clonal and frequency analyses of tumor-infiltrating T lymphocytes from human solid tumors.
Miescher S; Whiteside TL; Moretta L; von Fliedner V
J Immunol; 1987 Jun; 138(11):4004-11. PubMed ID: 3108380
[TBL] [Abstract][Full Text] [Related]
23. Specificity of auto-tumor cytotoxicity exerted by fresh, activated and propagated human T lymphocytes.
Vánky F; Klein E
Int J Cancer; 1982 May; 29(5):547-53. PubMed ID: 6178704
[TBL] [Abstract][Full Text] [Related]
24. Augmented local immunity in the liver by a streptococcal preparation, OK432, related to antitumor activity of hepatic macrophages.
Mise M; Arii S; Higashitsuji H; Furutani M; Monden K; Adachi Y; Funaki N; Fujita S; Ishiguro S; Kitao
Immunopharmacology; 1994; 27(1):31-41. PubMed ID: 8206752
[TBL] [Abstract][Full Text] [Related]
25. Lymphokine-activated killer (LAK) cell phenomenon. IV. Lysis by LAK cell clones of fresh human tumor cells from autologous and multiple allogeneic tumors.
Rayner AA; Grimm EA; Lotze MT; Wilson DJ; Rosenberg SA
J Natl Cancer Inst; 1985 Jul; 75(1):67-75. PubMed ID: 2989604
[TBL] [Abstract][Full Text] [Related]
26. Enhancement of tumor cell susceptibility to lymphokine-activated killer cells by treatment with the streptococcal preparation OK432.
Yamaue H; Tanimura H; Tsunoda T; Iwahashi M; Tani M; Tamai M; Noguchi K; Hotta T; Arii K
Biotherapy; 1992; 5(1):83-93. PubMed ID: 1389905
[TBL] [Abstract][Full Text] [Related]
27. Blastogenic responses of human lymphocytes to a streptococcal preparation OK-432 and its fractions.
Tanaka T; Kaneko Y; Haba F; Katsuta S; Tsutsui K; Tamaki S; Chen DR; Suzuki S; Ueda R; Yamamoto A
J Clin Lab Immunol; 1989 Feb; 28(2):91-6. PubMed ID: 2787407
[TBL] [Abstract][Full Text] [Related]
28. [Role of interleukin 2 and interferon gamma in induction of activated natural killer cells by the streptococcal preparation OK432].
Yamaue H; Tanimura H; Iwahashi M; Tani M; Tsunoda T; Tabuse K
Nihon Gan Chiryo Gakkai Shi; 1989 Dec; 24(11):2504-12. PubMed ID: 2515233
[TBL] [Abstract][Full Text] [Related]
29. Reduction of suppressor cell activities of human peripheral blood lymphocytes by a streptococcal preparation, OK-432.
Toge T; Yamada H; Aratani K; Yamaguchi M; Fujita T; Yanagawa E; Hattori T
Int J Immunopharmacol; 1987; 9(8):875-9. PubMed ID: 2892805
[TBL] [Abstract][Full Text] [Related]
30. Natural killer (NK) cell activating factor released from murine thymocytes stimulated with an anti-tumor streptococcal preparation, OK-432.
Shitara K; Ichimura O; Mitsuno T; Osawa T
J Immunol; 1985 Feb; 134(2):1039-47. PubMed ID: 2578148
[TBL] [Abstract][Full Text] [Related]
31. Induction of tumor necrosis factor by administration of OK-432 in cancer patients.
Kokunai I; Shimano T; Sekimoto K; Takeda T; Kobayashi T; Yayoi E; Yamamoto A; Mori T
J Clin Lab Immunol; 1986 Dec; 21(4):169-71. PubMed ID: 3560194
[TBL] [Abstract][Full Text] [Related]
32. Enhancement of rat hepatic macrophages by treatment with interleukin-2 and streptococcal preparation OK432, with reference to antitumor activity, soluble factor production and Ia expression.
Sasaoki T; Arii S; Monden K; Itai S; Adachi Y; Funaki N; Higashituji H; Tobe T
Cancer Immunol Immunother; 1992; 35(2):75-82. PubMed ID: 1317753
[TBL] [Abstract][Full Text] [Related]
33. Autologous tumor killing and natural cytotoxic activity of tumor-associated macrophages in cancer patients.
Yanagawa E; Uchida A; Moore M; Micksche M
Cancer Immunol Immunother; 1985; 19(3):163-7. PubMed ID: 2408742
[TBL] [Abstract][Full Text] [Related]
34. Lysis of fresh human tumor cells by autologous large granular lymphocytes from peripheral blood and pleural effusions.
Uchida A; Micksche M
Int J Cancer; 1983 Jul; 32(1):37-44. PubMed ID: 6862692
[TBL] [Abstract][Full Text] [Related]
35. Human CD3+ T lymphocytes that express neither CD4 nor CD8 antigens.
Lanier LL; Ruitenberg JJ; Phillips JH
J Exp Med; 1986 Jul; 164(1):339-44. PubMed ID: 2425030
[TBL] [Abstract][Full Text] [Related]
36. Lysis of tumor biopsy cells by autologous T lymphocytes activated in mixed cultures and propagated with T cell growth factor.
Vánky F; Gorsky T; Gorsky Y; Masucci MG; Klein E
J Exp Med; 1982 Jan; 155(1):83-95. PubMed ID: 6459402
[TBL] [Abstract][Full Text] [Related]
37. Autologous mixed lymphocyte-tumor reaction and autologous mixed lymphocyte reaction. I. Proliferation of two distinct T-cell subsets.
Uchida A; Moore M; Klein E
Int J Cancer; 1987 Aug; 40(2):165-70. PubMed ID: 2956198
[TBL] [Abstract][Full Text] [Related]
38. Human cytotoxic T cells specific for autologous melanoma cells: successful generation from lymph node cells in seven consecutive cases.
Slingluff CL; Darrow T; Vervaert C; Quinn-Allen MA; Seigler HF
J Natl Cancer Inst; 1988 Sep; 80(13):1016-26. PubMed ID: 3261800
[TBL] [Abstract][Full Text] [Related]
39. [Studies on human natural killer (NK) cell activity against cell lines derived from malignant urinary tract tumors. Part 3: Effects of OK432 on human NK cell activity and proliferation of tumor cells].
Hayakawa M; Marumo K; Nagakura K; Hata M; Fujioka T; Nakamura H; Murai M
Nihon Hinyokika Gakkai Zasshi; 1984 Jul; 75(7):1124-33. PubMed ID: 6542157
[No Abstract] [Full Text] [Related]
40. [Augmentation of cytotoxicity of tumor infiltrating lymphocytes by interleukin-2 in gastric cancer patients].
Gotoh K
Nihon Geka Gakkai Zasshi; 1985 Dec; 86(12):1600-7. PubMed ID: 3878935
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
